lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
---|---|---|---|---|---|---|---|---|---|---|---|
MALAT1 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | RNA-Seq | 2.0402632 | Upregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
MALAT1 | Human immunodeficiency virus type 1 (VSV-G-pseudotyped HIV-1 NL4-3) | MOI=Not provided;
72 hr |
Jurkat Human acute lymphoblastic leukemia cells | RNA-Seq | 3 | Upregulation | p < 0.05 | Disease-related Human LncRNA Profiler (System Biosciences) | Not provided | 2013 | 23362321 |
MALAT1 | Human immunodeficiency virus type 1 (VSV-G-pseudotyped HIV-1 NL4-3) | MOI=Not provided;
72 hr |
MT4Human T cell line | RNA-Seq | 2.8 | Upregulation | p < 0.05 | Disease-related Human LncRNA Profiler (System Biosciences) | Not provided | 2013 | 23362321 |
MALAT1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 3.250592377 | Upregulation | 0 | student's t test | 2020 | 32416070 | |
MALAT1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 4.106815115 | Upregulation | 0 | student's t test | 2020 | 32416070 | |
MALAT1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 2.339386119 | Upregulation | 1.33E-212 | student's t test | 2020 | 32416070 | |
ENSG00000251562 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Primary Human Bronchial epithelial (NHBE) cells | RNA-Seq | 5.054921373 | Upregulation | 0.00010486 | two-tailed t-test | 2020 | 32646047 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
8 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | >2 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
4 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.53 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
6 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.32 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
8 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.24 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
12 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.18 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Encephalomyocarditis virus (EMCV) | MOI: NA ;
4 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | RNA-Seq | 0.8 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Encephalomyocarditis virus (EMCV) | MOI: NA ;
8 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | Northern blotting | 0.5 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Encephalomyocarditis virus (EMCV) | MOI: NA ;
12 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | Northern blotting | 0.25 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Herpes simplex virus type 1 (HSV-1 ) | MOI: NA ;
4 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | Northern blotting | 0.78 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Herpes simplex virus type 1 (HSV-1 ) | MOI: NA ;
8 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | Northern blotting | 0.5 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Herpes simplex virus type 1 (HSV-1 ) | MOI: NA ;
12 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.25 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
4 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.7 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
8 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.5 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 | |
ENSMUST00000172812 | Vesicular stomatitis virus (VSV) | MOI: NA ;
12 hr |
RAW 264.7 Mouse monocyte/macrophage cell line | qPCR | 0.3 | Downregulation | p < 0.0001 | two-tailed unpaired student’s t test | 2020 | 32907941 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose